ALTuCELL
Business Services · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
561 Acorn St Ste I, Deer Park, New York,...Phone Number
(631) 586-4940Website
www.altucell.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About ALTuCELL
ALTUCELL, Inc. is a biotech company focused on addressing unmet needs in cell, molecular, and regenerative therapies for diabetes, autoimmune diseases, and neurodegenerative conditions. The company specializes in innovative technologies such as microencapsulation to enhance treatment efficacy. ALTUCELL aims to serve patients suffering from these chronic conditions by providing advanced therapeutic solutions. Their commitment to research and development positions them as a key player in the biotech industry.Explore more
ALTuCELL Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ALTuCELL your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at ALTuCELL
Product Launch: Get notified when ALTuCELL launches new products
Earning: See what the market has to say on ALTuCELL recently announced quarterly report
Check out if ALTuCELL is spiking on competitors!
Click to see if ALTuCELL had a recent Job posting/layoffs
ALTuCELL, which may be a good buyer, showed buying intent in Masked Content Topic
Check if ALTuCELL has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once ALTuCELL has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to ALTuCELL
Compare insights from companies similar to ALTuCELL, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
ALTuCELL is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
ALTuCELL is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about ALTuCELL.
ALTuCELL Tech Stack
A closer look at the technologies used by ALTuCELL
ALTuCELL News & Media
AltuCell Therapeutics Announces Proof-of-Concept in Lead Programs in Type 1 Diabetes in Human Subjects; Phase 1 Pilot in Humans Has IND Approval & Trial to Begin Shortly
AltuCell Therapeutics, Inc., AltuCell announced today the achievement of approval of IND in Italy after pre-clinical proof-of-concept based on data from its two lead programs for type 1 diabetes testing of cadaver stem cell-derived islets in both human and non-human subjects. Their capsules have been implanted in people with diabetes for 5 year, demonstrating long-term safety, with no toxicity or tissue necrosis, and no [PR.com]Generex Biotechnology Signs Stock Purchase Agreement to Acquire 51% of ALTuCELL, Inc.
MIRAMAR, Fla., Nov. 25, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (OTCQB: GNBT) is excited to announce that the Company has signed a Stock Purchase Agreement to acquire a 51% controlling interest in ALTuCELL, a privately held biotechnology company, in a stock and cash transaction. With this agreement, Generex gains a broad patent portfolio for cell encapsulation technology and cellular therapy. The transaction is expected to close by the end of the year.Generex Biotechnology Signs Letter of Intent to Acquire 51% in ALTuCELL, Inc. and their Cellular Therapy Product Altsulin® with Patented Microencapsulation Technology for the Treatment of Type I Diabetes Mellitis
MIRAMAR, Fla., Sept. 09, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (OTCQB: GNBT) is pleased to announce that the Company has signed a binding letter of intent (LOI) to partner with ALTuCELL, a privately held biotechnology company in a stock and cash transaction. ALTuCELL, Inc. is a cellular engineering and biotech company backed by sound research and science focused on fulfilling a large "unmet need" in cell, molecular and regenerative therapy for treatment of diabetes
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding ALTuCELL
Sign Up For FreeTo access detailed company insights
ALTUCELL, Inc. is a biotech company focused on addressing unmet needs in cell, molecular, and regenerative therapies for diabetes, autoimmune diseases, and neurodegenerative conditions. The company specializes in innovative technologies such as microencapsulation to enhance treatment efficacy. ALTUCELL aims to serve patients suffering from these ch... Read More
